Genetic and Immunologic Basis of COVID-19 Infection

Active, not recruiting

• Conditions: Genetic Basis of COVID-19 Infection

• Registration Number: NCT04384250
• Lead Sponsor: Mansoura University

Brief Summary

We will study genetic factors causing severe disease due to infection with SARS-COV-2 which may help to find targeted therapy

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study First Submitted: 2020-05-10
• Study First Submitted QC: 2020-05-10
• Study First Posted: 2020-05-12
• Study Start: 2020-06-01
• Status Verified: 2023-05
• Last Update Submitted: 2023-05-14
• Last Update Posted: 2023-05-16
• Primary Completion: 2023-12-30
• Study Completion: 2024-12-30

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

• severe COVID-19 infection

Read More

Exclusion Criteria

• Comorbidity ((DM, hypertension, Chronic liver or Kidney diseases, HIV, morbid obesity, Malignancy, Immunosuppressive therapy)

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mutations leading to increase susceptibility to SARS-COV-2 infection	12 months	Genetic susceptibility to COVID-19

Trial Locations

Locations (1)

Mansoura University; 🇪🇬 Mansoura, Dakahlyia, Egypt